JP2021517895A5 - - Google Patents

Info

Publication number
JP2021517895A5
JP2021517895A5 JP2020548799A JP2020548799A JP2021517895A5 JP 2021517895 A5 JP2021517895 A5 JP 2021517895A5 JP 2020548799 A JP2020548799 A JP 2020548799A JP 2020548799 A JP2020548799 A JP 2020548799A JP 2021517895 A5 JP2021517895 A5 JP 2021517895A5
Authority
JP
Japan
Prior art keywords
cells
hpv
modified immune
immune cells
adjuvant
Prior art date
Application number
JP2020548799A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019178005A5 (https=
JP2021517895A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/021703 external-priority patent/WO2019178005A2/en
Publication of JP2021517895A publication Critical patent/JP2021517895A/ja
Publication of JP2021517895A5 publication Critical patent/JP2021517895A5/ja
Publication of JPWO2019178005A5 publication Critical patent/JPWO2019178005A5/ja
Pending legal-status Critical Current

Links

JP2020548799A 2018-03-12 2019-03-11 Hpv関連疾患を処置するための方法 Pending JP2021517895A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201862641988P 2018-03-12 2018-03-12
US62/641,988 2018-03-12
US201962794517P 2019-01-18 2019-01-18
US62/794,517 2019-01-18
US201962812225P 2019-02-28 2019-02-28
US62/812,225 2019-02-28
PCT/US2019/021703 WO2019178005A2 (en) 2018-03-12 2019-03-11 Methods for treating hpv-associated diseases

Publications (3)

Publication Number Publication Date
JP2021517895A JP2021517895A (ja) 2021-07-29
JP2021517895A5 true JP2021517895A5 (https=) 2022-03-22
JPWO2019178005A5 JPWO2019178005A5 (https=) 2022-03-22

Family

ID=65904594

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020548799A Pending JP2021517895A (ja) 2018-03-12 2019-03-11 Hpv関連疾患を処置するための方法

Country Status (18)

Country Link
US (1) US12599656B2 (https=)
EP (1) EP3765073A2 (https=)
JP (1) JP2021517895A (https=)
KR (1) KR20200130371A (https=)
CN (1) CN112105383A (https=)
AU (1) AU2019234549B2 (https=)
BR (1) BR112020018609A2 (https=)
CA (1) CA3093826A1 (https=)
CO (1) CO2020012583A2 (https=)
CR (1) CR20200461A (https=)
IL (1) IL277190B2 (https=)
MA (1) MA52003A (https=)
MX (1) MX2020009441A (https=)
PE (1) PE20201201A1 (https=)
PH (1) PH12020551437A1 (https=)
SG (1) SG11202008863XA (https=)
TW (1) TW202003025A (https=)
WO (1) WO2019178005A2 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3344575B1 (en) 2015-09-04 2020-04-15 SQZ Biotechnologies Company Intracellular delivery of biomolecules to cells comprising a cell wall
JP7602702B2 (ja) 2016-05-03 2024-12-19 ステムセル テクノロジーズ カナダ インコーポレーテッド 寛容性を誘導するための生体分子の細胞内送達
EP3765068A2 (en) * 2018-03-12 2021-01-20 SQZ Biotechnologies Company Intracellular delivery of biomolecules to modify immune response
US12599656B2 (en) 2018-03-12 2026-04-14 Stemcell Technologies Canada Inc. Methods for treating HPV-associated diseases
CA3131701A1 (en) 2019-02-28 2020-09-03 Sqz Biotechnologies Company Delivery of biomolecules to pbmcs to modify an immune response
US11679388B2 (en) 2019-04-08 2023-06-20 Sqz Biotechnologies Company Cartridge for use in a system for delivery of a payload into a cell
JP2022533956A (ja) 2019-05-14 2022-07-27 プロメテウス バイオサイエンシーズ,インク. Tl1a患者を選択する方法、システム、およびデバイス
CN112007149A (zh) * 2019-05-29 2020-12-01 思格(苏州)生物科技有限公司 一种新型复合免疫佐剂及其应用
CN110846318A (zh) * 2019-11-29 2020-02-28 华中科技大学同济医学院附属同济医院 治疗hpv感染的纳米粒制剂中新的靶向序列以及新pbae的制备方法
AU2021272340A1 (en) 2020-05-11 2022-12-08 F. Hoffmann-La Roche Ag Combination therapy with modified pbmcs and an immunoconjugate
JP2023534740A (ja) * 2020-07-24 2023-08-10 四川大学華西医院 Ebvを標的とした同種異系b細胞ワクチン及びその調製方法
EP4188425B1 (en) 2020-07-29 2025-05-14 Stemcell Technologies Canada Inc. Methods to stimulate immune responses to mutant ras using anucleate cells
WO2022026620A1 (en) 2020-07-29 2022-02-03 Sqz Biotechnologies Company Methods to stimulate immune responses to mutant ras using nucleated cells
KR20230079066A (ko) * 2020-09-02 2023-06-05 에스큐지 바이오테크놀로지스 컴퍼니 유핵 세포를 사용하여 단백질에 대한 hla-불문 면역 반응을 자극하는 방법
US20220233676A1 (en) 2020-12-29 2022-07-28 Sqz Biotechnologies Company Formulations of activating antigen carriers
US20220296691A1 (en) * 2020-12-29 2022-09-22 Sqz Biotechnologies Company Methods for treating cancer with activating antigen carriers
JP2024503279A (ja) 2020-12-29 2024-01-25 スクイーズ バイオテクノロジーズ カンパニー Pbmcの凍結保存のための製剤
TW202241466A (zh) * 2020-12-29 2022-11-01 美商Sqz生物科技公司 以經修飾pbmc治療癌症之方法
WO2023010090A1 (en) 2021-07-29 2023-02-02 Sqz Biotechnologies Company Methods to generate enhanced tumor infiltrating lymphocytes through microfluidic delivery
WO2023087009A1 (en) 2021-11-11 2023-05-19 Sqz Biotechnologies Company Methods to generate enhanced tumor infiltrating lymphocytes through microfluidic delivery
WO2023196884A1 (en) 2022-04-06 2023-10-12 Juno Therapeutics, Inc. Detection assay for human papillomavirus (hpv) type 16 (hpv-16)
CA3262748A1 (en) 2022-07-28 2024-02-01 Stemcell Technologies Canada Inc. IMPROVED ANTIGEN-PRESENTING CELL FORMULATIONS
CA3262756A1 (en) 2022-07-28 2024-02-01 Stemcell Technologies Canada Inc. CANCER TREATMENT METHODS WITH ENHANCED ANTIGEN-PRESENTING CELLS

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2502621C3 (de) 1975-01-23 1978-09-14 Kernforschungsanlage Juelich Gmbh, 5170 Juelich Messung elastischer und dielektrischer Eigenschaften der Membran lebender Zellen
US4376634A (en) 1980-05-30 1983-03-15 Mallinckrodt, Inc. Assay kit having syringe, dilution device and reagents within sealed container
FR2569477B1 (fr) 1984-08-24 1987-01-02 Descartes Universite Rene Appareil et procede pour la determination de la deformabilite des globules rouges du sang
JP2720161B2 (ja) 1988-02-01 1998-02-25 株式会社アドバンス 細胞変形能測定装置
JP2685544B2 (ja) 1988-11-11 1997-12-03 株式会社日立製作所 血液フィルタおよび血液検査方法並びに血液検査装置
JP2532707B2 (ja) 1990-03-08 1996-09-11 佑二 菊池 血液回路及びこれを用いた血液測定装置及び血液測定方法
AU2002252073A1 (en) 2001-02-22 2002-09-12 The Scepens Eye Research Institute, Inc. Tolerogenic antigen presenting cells and in treating immune-inflammatory conditions
WO2003020039A1 (en) 2001-08-28 2003-03-13 Rush-Presbyterian-St. Luke's Medical Center Immune tolerance to predetermined antigens
EP1411351A4 (en) 2002-06-05 2010-07-07 Panasonic Corp DEVICE FOR MEASURING THE EXTRACELLULAR POTENTIAL AND METHOD FOR PRODUCING THE DEVICE
US20060134067A1 (en) 2003-02-18 2006-06-22 Maxcyte, Inc. Loading of cells with antigens by electroporation
JP2007528838A (ja) 2003-12-24 2007-10-18 ライデン ユニバーシティ メディカル センター 腫瘍特異的ワクチンとしての合成タンパク質
CA2928387A1 (en) 2004-05-03 2005-11-17 Merrimack Pharmaceuticals, Inc. Drug delivery liposomes containing anionic polyols or anionic sugars
WO2005123905A1 (ja) 2004-06-17 2005-12-29 Ken Nakata 生体力学的刺激負荷による細胞培養方法及びその装置
CN100591761C (zh) 2004-08-19 2010-02-24 加的夫大学学院咨询有限公司 呈递抗原的人γδT细胞的制备和在免疫治疗中的用途
US20060134772A1 (en) 2004-11-18 2006-06-22 The Regents Of The University Of California System for locating cells and for cellular analysis
US7704743B2 (en) 2005-03-30 2010-04-27 Georgia Tech Research Corporation Electrosonic cell manipulation device and method of use thereof
EP3263581B2 (en) 2005-05-17 2025-07-09 University of Connecticut Compositions and methods for immunomodulation in an organism
WO2007067032A1 (en) 2005-12-09 2007-06-14 Academisch Medisch Cemtrum Bij De Universiteit Van Amsterdam Means and methods for influencing the stability of cells
US8293524B2 (en) 2006-03-31 2012-10-23 Fluxion Biosciences Inc. Methods and apparatus for the manipulation of particle suspensions and testing thereof
US20070249038A1 (en) 2006-04-21 2007-10-25 Andrea Adamo Microfluidic device for single cell targeted operations
AU2007284454A1 (en) 2006-08-17 2008-02-21 Massachusetts Institute Of Technology Method and apparatus for microfluidic injection
WO2008046251A1 (fr) * 2006-10-19 2008-04-24 Sunbio Biotech Pharmaceuticals(Tianjin) Co., Ltd. Protéines hybrides contenant un domaine n de la calréticuline humaine et des protéines e6 ou e7 du papillomavirus humain de type 16, et utilisations associées
WO2008098094A1 (en) 2007-02-06 2008-08-14 Network Biosystems, Inc. Devices and methods for the performance of miniaturized in vitro assays
US20080311140A1 (en) 2007-05-29 2008-12-18 Baylor College Of Medicine Antigen specific immunosuppression by dendritic cell therapy
ES2482192T3 (es) 2007-05-31 2014-08-01 Academisch Ziekenhuis Leiden H.O.D.N. Lumc Vacunación intradérmica del péptido de HPV
FR2919804B1 (fr) 2007-08-08 2010-08-27 Erytech Pharma Composition et vaccin therapeutique anti-tumoral
GB0718160D0 (en) 2007-09-18 2007-10-24 Medical Res Council Methods
EP2216639A4 (en) 2007-11-28 2014-01-15 Konica Minolta Opto Inc APPARATUS AND METHOD FOR MEASURING BLOOD FLUIDITY
US20090280518A1 (en) 2008-05-12 2009-11-12 Massachusetts Institute Of Technology System for high throughput measurement of mechanical properties of cells
JP5137129B2 (ja) 2008-07-23 2013-02-06 国立大学法人山口大学 血液細胞の力学的特性測定装置
EP2321405A4 (en) 2008-08-08 2012-09-12 Agency Science Tech & Res Microfluidic continuous flow device
MX2011012147A (es) 2009-05-15 2012-06-19 Irx Therapeutics Inc Inmunoterapia de vacuna.
US20110300205A1 (en) 2009-07-06 2011-12-08 Novartis Ag Self replicating rna molecules and uses thereof
US9364831B2 (en) 2009-08-08 2016-06-14 The Regents Of The University Of California Pulsed laser triggered high speed microfluidic switch and applications in fluorescent activated cell sorting
HRP20161223T1 (hr) 2009-10-27 2016-11-18 Erytech Pharma Pripravak za induciranje specifične imune tolerancije
EP2516320A4 (en) 2009-12-23 2015-03-04 Cytovera Inc SYSTEM AND METHOD FOR PARTICLE FILTRATION
US20110293558A1 (en) 2010-03-22 2011-12-01 Massachusetts Institute Of Technology Material properties of t cells and related methods and compositions
ES2924027T3 (es) 2010-11-25 2022-10-04 Imcyse Sa Péptidos inmunogénicos para su uso en la prevención y/o tratamiento de enfermedades infecciosas, enfermedades autoinmunitarias, respuestas inmunitarias a alofactores, enfermedades alérgicas, tumores, rechazo de injerto y respuestas inmunitarias contra vectores virales usados para terapia génica o vacunación génica
CN107058101B (zh) 2011-10-17 2021-06-01 麻省理工学院 细胞内传递
JP2015520194A (ja) 2012-06-07 2015-07-16 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 薬物標的指向化のためのナノ療法
AU2014248119B2 (en) 2013-04-03 2019-06-20 Memorial Sloan-Kettering Cancer Center Effective generation of tumor-targeted T-cells derived from pluripotent stem cells
CN110511960B (zh) * 2013-07-15 2023-05-23 美国卫生和人力服务部 抗人乳头瘤病毒16 e6 t细胞受体
EP3033184B1 (en) 2013-08-16 2021-03-31 Massachusetts Institute of Technology Selective delivery of material to cells
JP7523203B2 (ja) 2014-10-31 2024-07-26 マサチューセッツ インスティテュート オブ テクノロジー 生体分子の免疫細胞への送達
HUE040440T2 (hu) * 2014-11-04 2019-03-28 Janssen Vaccines & Prevention Bv Terápiás HPV16-oltóanyagok
WO2016077761A1 (en) 2014-11-14 2016-05-19 Massachusetts Institute Of Technology Disruption and field enabled delivery of compounds and compositions into cells
CN107250373A (zh) 2015-01-12 2017-10-13 麻省理工学院 通过微流体递送实现的基因编辑
SG10201912910PA (en) 2015-07-09 2020-02-27 Massachusetts Inst Technology Delivery of materials to anucleate cells
ES2930017T3 (es) 2015-09-04 2022-12-05 Sqz Biotechnologies Co Suministro intracelular de biomoléculas mediado por una superficie con poros
EP3344575B1 (en) 2015-09-04 2020-04-15 SQZ Biotechnologies Company Intracellular delivery of biomolecules to cells comprising a cell wall
EP3397263B1 (en) 2015-12-30 2023-09-20 Celgene Corporation T lymphocyte production methods and t lymphocytes produced thereby
CN108779475A (zh) 2016-01-12 2018-11-09 Sqz生物技术公司 复合物的细胞内递送
JP7602702B2 (ja) 2016-05-03 2024-12-19 ステムセル テクノロジーズ カナダ インコーポレーテッド 寛容性を誘導するための生体分子の細胞内送達
KR102490952B1 (ko) 2016-05-03 2023-01-19 에스큐지 바이오테크놀로지스 컴퍼니 관용을 유도하는 생체분자의 세포내 전달
US11422127B2 (en) 2016-12-07 2022-08-23 Albany Medical College Ex vivo antigen and adjuvant pulsed peripheral blood mononuclear cells as a screening platform for candidate novel vaccines and candidate antigens
CN106632694B (zh) * 2017-01-24 2021-02-12 南京益康生物医药有限公司 一种重组蛋白及药物组合物与应用
EP3720878A1 (en) 2017-12-05 2020-10-14 SQZ Biotechnologies Company Intracellular delivery of biomolecules to modulate antibody production
JP2021506309A (ja) 2017-12-20 2021-02-22 スクイーズ バイオテクノロジーズ カンパニー 細胞の中へのペイロードの送達のためのシステム
US12599656B2 (en) 2018-03-12 2026-04-14 Stemcell Technologies Canada Inc. Methods for treating HPV-associated diseases
EP3765068A2 (en) 2018-03-12 2021-01-20 SQZ Biotechnologies Company Intracellular delivery of biomolecules to modify immune response
KR20210070338A (ko) 2018-10-04 2021-06-14 에스큐지 바이오테크놀로지스 컴퍼니 항원 제시 세포 기능을 증진시키기 위한 생체분자의 세포내 전달
WO2020154696A1 (en) 2019-01-25 2020-07-30 Sqz Biotechnologies Company Anucleate cell-derived vaccines
CA3131701A1 (en) 2019-02-28 2020-09-03 Sqz Biotechnologies Company Delivery of biomolecules to pbmcs to modify an immune response
US11679388B2 (en) 2019-04-08 2023-06-20 Sqz Biotechnologies Company Cartridge for use in a system for delivery of a payload into a cell

Similar Documents

Publication Publication Date Title
JP2021517895A5 (https=)
JP2021517813A5 (https=)
Ramos da Silva et al. Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice
JPWO2019178005A5 (https=)
US12252699B2 (en) Method for generating t-cells compatible for allogenic transplantation
TWI904084B (zh) 投遞生物分子至周邊血液單核細胞(pbmc)以調節免疫反應
JP5070045B2 (ja) 新規人工抗原提示細胞およびそれらの用途
Xie et al. The role of CD4+ T cells in tumor and chronic viral immune responses
Rickinson et al. Cellular immune controls over Epstein–Barr virus infection: new lessons from the clinic and the laboratory
IL277188B2 (en) Intracellular delivery of biomolecules to modify the immune response
BR112021003305A2 (pt) métodos para produzir células que expressam receptor de antígeno quimérico
Salerno-Gonçalves et al. Cell-mediated immunity and the challenges for vaccine development
JP2017533702A (ja) 生体分子の免疫細胞への送達
CN105378068A (zh) 用于免疫治疗的同种异体且高活性的t细胞的工程化方法
CN104411819A (zh) 用于过继细胞疗法的改进的细胞培养方法
JPWO2019178006A5 (https=)
Tellam et al. mRNA Structural constraints on EBNA1 synthesis impact on in vivo antigen presentation and early priming of CD8+ T cells
CA2831294A1 (en) Compositions and methods to immunize against hepatitis c virus
O'Sullivan et al. Generation of natural killer cell memory during viral infection
US20230263879A1 (en) Methods to stimulate hla-agnostic immune responses to proteins using nucleated cells
JP2022514116A (ja) 新規な癌抗原及び方法
Zanetti et al. B lymphocytes as antigen‐presenting cell‐based genetic vaccines
Garidou et al. Therapeutic memory T cells require costimulation for effective clearance of a persistent viral infection
Tzannou et al. Accelerating immune reconstitution after hematopoietic stem cell transplantation
JP7519418B2 (ja) Cd40およびsting経路を活性化する遺伝子アジュバントの発現のためのウイルスベクター構築物